Genentech Logo
Banner Image
Banner Image

Media

Newsroom

The Media section provides reporters with easy access to Genentech information for stories in development. It also houses our recent and archived press releases.

News Events

Genentech Medicine Approved For Advanced Basal Cell Carcinoma
On January 30, 2012, the FDA approved a Genentech medicine for the treatment of adults with a type of skin cancer, called basal cell carcinoma, that has spread to other parts of the body or that has come back after surgery or that their healthcare provider decides cannot be treated with surgery or radiation. View information and materials on the approval

Genentech Medicine Approved For Certain Type Of Melanoma
On August 17, 2011, the FDA approved a Genentech medicine for a type of inoperable and metastatic melanoma. View information and materials on the approval

Genentech Medicine Approved in Stomach Cancer
On October 20, 2010, a Genentech medicine was approved by the U.S. Food and Drug Administration (FDA) for stomach cancer. View information and materials on the approval

Media Highlights

The Economist covers Roche, its acquisition of Genentech and investment in science in its December 10, 2009 issue (204K/PDF)

BusinessWeek highlights the Roche and Genentech integration in its Dec 7, 2009 issue (512K/PDF)


Recent Press Releases

Feb 7, 2012
FDA Grants Genentech's Pertuzumab Priority Review for Previously Untreated HER2-Positive Metastatic Breast Cancer

Jan 30, 2012
FDA Approves Erivedge (Vismodegib) Capsule, the First Medicine for Adults with Advanced Basal Cell Carcinoma

Jan 13, 2012
Genentech Announces First Milestone Payment to Device-Maker ForSight VISION4, Inc. in Development of Sustained Delivery Lucentis

Dec 7, 2011
Genentech Announces Positive Results of Pivotal Phase III Study with Pertuzumab in HER2-Positive Metastatic Breast Cancer
MEDIA INQUIRIES

If you are a member of the media, please call our Corporate Relations department.

Corporate Relations: (650) 467-6800

HELPFUL LINKS

Disease Education
Research Focus Areas
Development Pipeline
Product Information
Product Timeline
Historical Product Sales
Management Bios
Views on Public Policy

SIGN UP FOR GENENTECH NEWS

Receive e-mail alert messages whenever a new press release is posted to this site.

FOLLOW GENENTECH ON TWITTER

Twitter LogoFollow Genentech on Twitter to receive the latest news and updates about the company.

NEWSROOM FEEDBACK

Please take a moment to fill out our .

We're improving our newsroom.

We're aiming to build the kind of digital newsroom you'd love to visit, the kind that has exactly the resources and information you're looking for. And we'd really appreciate your help.

So we've put together a short survey to help us understand which resources you value, and which ones you don't.

It should take less than 3 minutes to complete.

Thanks!

Take the Survey